and Biobank consortium
Together patients, scientists and clinicians can make a difference for ME/CFS. We have bundled our knowledge and expertise in the NMCB consortium. Together we will spearhead biomedical research on ME/CFS in the Netherlands. And more! Join our effort!
What is ME/CFS?
ME/CFS
ME/CFS is a serious disease that disrupts patients’ lives and causes a lot of suffering. ME/CFS patients experience constant and intense exhaustion, as well as a worsening of symptoms after even minimal cognitive, physical, emotional or social activity – something known as “post-exertional malaise” (PEM).
ME/CFS symptoms:
- Post-exertional malaise (PEM)
- Muscle pain, headache
- Poor sleep quality
- Hypersensitivity to stimuli
- Overall feeling of illness and exhaustion
- Cognitive problems
WHAT WILL NMCB DO?
Building an international ME/CFS hub
Biomedical research
Despite the impact of ME/CFS, much is still unknown about its causes and possible treatments. NMCB recognizes the need for biomedical research on ME/CFS. By establishing a national patient cohort and biobank, we are building an international infrastructure for research to improve the knowledge, diagnosis and treatment of ME/CFS.
NMCB research
In an eight-year collaboration between scientific and clinical experts, as well as patients, NMCB will enable in-depth research divided initially into six subprojects. In collaboration with an international research network, the NMCB will establish an international ME/CFS hub to facilitate additional research on ME/CFS.
Collaborations
Patient representatives
Patients and their experiences are an essential part of NMCB. In collaboration with three ME/CFS patient organisations, we want to ensure that patients’ experiences remain central to our studies.
26/08/2024
- News
12/05/2024
- News
Get in Touch
Contacts
Do you have any questions about the NMCB? Feel free to reach out using the form below, or find your question at the FAQ page.